Enliven Therapeutics, Inc. Common Stock
$44.75
▼ 0.42
(-0.93%)
Volume: 963,786
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -26.5%
- MA aligned bearish
- RSI 20 oversold
🎯
Pullback
76
- RSI 20 near lows
- Near lower Bollinger band
- -16.2% vs 20MA
💎
Value
58
- -28% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)20.5
MACD-1
MA trendBearish
ATR4.90%
21d mom.-26.5%
63d mom.-10.6%
vs 20MA-16.2%
RVOL(20)0.68×
52w low · 15
52w high · 62
-28.2% from 52-week high
20d support 44
· resistance 61
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$3.3B
PER—
PBR3.70
PSR—
EPS$-1.45
ROE-11.8%
ROA-11.6%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-25.54
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -9.50% | -26.48% | -10.64% | +13.90% | +133.07% | +187.97% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -24.56%, daily vol 2.20%. Enliven Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.